Canine CD8 alpha Antibody Summary
Ser22-Glu186
Accession # P33706
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
CD8 alpha in Canine PBMCs. CD8a was detected in immersion fixed canine peripheral blood mononuclear cells (PBMCs) using Mouse Anti-Canine CD8a alpha Monoclonal Antibody (Catalog # MAB6709) at 25 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). Specific staining was localized to cell membrane. View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CD8
CD8 is a dimeric complex made up of two Ig superfamily members. The CD8 alpha chain is a 34 kDa type I transmembrane glycoprotein that is disulfide-linked either to itself forming CD8 alpha alpha, or to an unrelated 30‑35 kDa CD8 beta chain, forming CD8 alpha beta. CD8 alpha contains one V-type Ig-like domain in its extracellular region (ECD) that binds to class I MHC molecules. CD8 alpha beta is a TCR coreceptor, while CD8 alpha alpha promotes T cell survival and differentation. Within the ECD, canine CD8 alpha shares 63%, 45%, 43%, 68%, and 54% amino acid identity with human, mouse, rat, feline, and porcine CD8 alpha, respectively.
Product Datasheets
Citation for Canine CD8 alpha Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer
Authors: HA Doyle, RJ Gee, TD Masters, CR Gee, CJ Booth, E Peterson-R, RA Koski, SC Helfand, L Price, D Bascombe, D Jackson, R Ho, GR Post, MJ Mamula
Translational Oncology, 2021-08-19;14(11):101205.
Species: Canine
Sample Types: Whole Cells
Applications: IHC
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Canine CD8 alpha Antibody
There are currently no reviews for this product. Be the first to review Canine CD8 alpha Antibody and earn rewards!
Have you used Canine CD8 alpha Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image